Asthma is a multifactorial disease influenced by genetic and environmental factors. In the past decade, several loci and >100 genes have been found to be associated with the disease in at least one population. Among these loci, region 12q13-24 has been implicated in asthma etiology in multiple populations, suggesting that it harbors one or more asthma susceptibility genes. We performed linkage and association analyses by transmission/disequilibrium test and case-control analysis in the candidate region 12q13-24, using the Sardinian founder population, in which limited heterogeneity of pathogenetic alleles for monogenic and complex disorders as well as of environmental conditions should facilitate the study of multifactorial traits. We analyzed our cohort, using a cutoff age of 13 years at asthma onset, and detected significant linkage to a portion of 12q13-24. We identified IRAK-M as the gene contributing to the linkage and showed that it is associated with early-onset persistent asthma. We defined protective and predisposing SNP haplotypes and replicated associations in an outbred Italian population. Sequence analysis in patients found mutations, including inactivating lesions, in the IRAK-M coding region. Immunohistochemistry of lung biopsies showed that IRAK-M is highly expressed in epithelial cells. We report that IRAK-M is involved in the pathogenesis of early-onset persistent asthma. IRAK-M, a negative regulator of the Toll-like receptor/IL-1R pathways, is a master regulator of NF- kappa B and inflammation. Our data suggest a mechanistic link between hyperactivation of the innate immune system and chronic airway inflammation and indicate IRAK-M as a potential target for therapeutic intervention against asthma.
The P-N bond hydrolysis of the 4-methoxyphenyl-ammonium ethylamido-phosphonodithioato ligand during its complexation to NiII leads to the first example of phosphonodithioato nickel(II) complex having a cis configuration; this complex is stabilised in the solid state by an extensive and intricate network of hydrogen bondings involving the released ethylenediamine and a water molecule.
In this paper we present the experimental results obtained from phenyl acetate hydrolysis in a
microwave-irradiated environment and in water solutions containing catalytic acetate ions. The
kinetics of the reaction were studied in an irradiated environment where radiation, at a frequency
of 2.45 GHz, was given to the reacting system at a power of 0.500 ± 0.025 W. The energy absorbed
by the reacting system was measured using a directional coupler, which can separate the
radiation directed to the reactor from any reflected one. The system was irradiated with a power
greater than that required to run the reaction; however, any energy in excess of that absorbed
by the reaction was quite easily taken up by a thermostatic system. In this way the reaction
system could run without any thermal effect due to radiation. The temperature was set at 25
°C and was kept constant during the reaction by using carbon tetrachloride as the thermostating
fluid. The results obtained show that the kinetics of the reaction studied were greatly enhanced
with respect to those of the reaction running in a nonirradiated environment. The kinetic constant
at zero concentration of the catalytic species rises from 1.92 × 10-4 h-1 in a nonirradiated
environment to the value 27.58 × 10-4 h-1 found here. The observed kinetic constant retains
the same value for all of the studied catalytic acetate ion concentrations. This fact suggests
that microwave radiation produces something like a catalytic effect which can replace that given
by acetate ions in nonirradiated environments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.